Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.16939 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.12552 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.12763 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.05617 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.02949 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.24973 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.16189 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.09157 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.08025 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.12237 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.11282 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.0541 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.13709 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.11624 | 48 |